ZUG, Switzerland, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today ...
--EyePoint Pharmaceuticals, Inc., a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced details ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now (Reuters) — Google said on Thursday it had ...
Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with globally renowned retina experts If ...
MADISON (WKOW) -- The CDC says nearly 40 million Americans have diabetes, and one in four them will develop some form of blindness from diabetic eye disease, the leading cause of blindness in ...
CALGARY, Alberta--(BUSINESS WIRE)--Orpyx® Medical Technologies Inc., a leader in sensor-based remote monitoring, today announced the launch of its next-generation sensory insole program, a proactive, ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Family physicians are effective in their classifications of diabetic retinopathy using a telemedicine ...
A multicenter randomized controlled trial was conducted to assess the impact of a web-based, diabetes evaluation portal and team-based care on outcomes in patients with diabetic kidney disease. A ...
UnitedHealth Group Incorporated’s UNH business, UnitedHealthcare, recently unveiled plans to introduce its community-based program, UnitedHealthcare Catalyst, across Southwest Georgia. The purpose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results